Stockreport

Dermavant to Present New ADORING Data Including Treatment of Patients with Skin of Color from Phase 3 Trials of VTAMA® (tapinarof) Cream, 1% in Adults and Children 2 Years of Age and Older...

Roivant Sciences Ltd.  (ROIV) 
PDF LONG BEACH, Calif. & BASEL, Switzerland, March 01, 2024 BUSINESS WIRE )--Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing inn [Read more]